Understanding Immix Biopharma Inc (IMMX)’s financial health through ratios

Immix Biopharma Inc (NASDAQ: IMMX) closed the day trading at $3.23 up 6.60% from the previous closing price of $3.03. In other words, the price has increased by $+0.2000 from its previous closing price. On the day, 503575 shares were traded.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.


For a better understanding of IMMX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.90 and its Current Ratio is at 7.90. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 11 when Hsu Jason bought 31,000 shares for $4.67 per share. The transaction valued at 144,894 led to the insider holds 813,000 shares of the business.

Hsu Jason bought 25,000 shares of IMMX for $122,025 on Dec 08. The Director now owns 782,000 shares after completing the transaction at $4.88 per share. On Sep 15, another insider, Hsu Jason, who serves as the Director of the company, bought 7,000 shares for $2.49 each. As a result, the insider paid 17,396 and bolstered with 757,000 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IMMX now has a Market Capitalization of 65.00M and an Enterprise Value of 45.99M.

Stock Price History:

Over the past 52 weeks, IMMX has reached a high of $7.75, while it has fallen to a 52-week low of $1.40. The 50-Day Moving Average of the stock is 5.3208, while the 200-Day Moving Average is calculated to be 3.3276.

Shares Statistics:

Over the past 3-months, IMMX traded about 337.34K shares per day on average, while over the past 10 days, IMMX traded about 539.47k shares per day. A total of 13.23M shares are outstanding, with a floating share count of 7.63M. Insiders hold about 61.10% of the company’s shares, while institutions hold 9.94% stake in the company. Shares short for IMMX as of Jan 11, 2024 were 219.52k with a Short Ratio of 0.22M, compared to 139.79k on Dec 14, 2023. Therefore, it implies a Short% of Shares Outstanding of 1.10% and a Short% of Float of 1.69%.

Earnings Estimates

Current recommendations for the stock of the company come from 1 analysts. On average, analysts expect EPS of -$0.23 for the current quarter, with a high estimate of -$0.23 and a low estimate of -$0.23, while EPS last year was -$0.27. The consensus estimate for the next quarter is -$0.23, with high estimates of -$0.23 and low estimates of -$0.23.

Analysts are recommending an EPS of between -$0.7 and -$0.89 for the fiscal current year, implying an average EPS of -$0.79. EPS for the following year is -$0.88, with 2 analysts recommending between -$0.88 and -$0.89.

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular